Clinical Trials Logo

Post-Stroke Spasticity clinical trials

View clinical trials related to Post-Stroke Spasticity.

Filter by:
  • None
  • Page 1

NCT ID: NCT06381999 Completed - Clinical trials for Post-stroke Spasticity

Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool

I-REFER
Start date: October 27, 2023
Phase:
Study type: Observational

The aim of this study is to investigate the validity and Inter-rater reliability for early recognition of spasticity by nurses and physiotherapists using the decision tree tool.

NCT ID: NCT04649632 Completed - Clinical trials for Post Stroke Spasticity

Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database.

Relax
Start date: April 29, 2020
Phase:
Study type: Observational

Determining the mean/median time between botulinum toxin-A injection within the treatment of patients with spasticity after stroke in relation to the botulinum toxin dose from a healthcare insurance database in the Netherlands.

NCT ID: NCT03459066 Completed - Clinical trials for Post Stroke Spasticity

Predictors Factors and Time of Onset of Spasticity and Their Relationship With the Functionality and Quality of Life.

Start date: October 1, 2018
Phase:
Study type: Observational [Patient Registry]

Spasticity is part of the syndrome motor neuron following a Stroke. It is a clinical sign of great complexity that generates disability, limiting the function and altering the quality of life of the subjects, generating great impact on families and society. Identify times and characteristics of appearance; as well as its predictive factors can support an early intervention, orienting and strengthening the work of the rehabilitation team. Determine the times of establishment, location and factors that favor the development of spasticity in acute stage and how it influences the functionality, quality of life and emotional level of post-stroke patients in hospital facilities. Through this proposal, it is proposed to generate a new line of research that allows the development of scientific evidence in the area of neurorehabilitation, specifically in the field of spasticity, through the identification of establishment times, affected structures and predominant patterns in the extremities; as well as determining factors that favor the development of spasticity and its impact on post-stroke functionality and quality of life. This information will strengthen the rehabilitative process of these subjects and the actions of the rehabilitation team, supporting the identification of preventive measures and implementing effective interventions that allow achieving better motor and functional results, in search of an optimal recovery.

NCT ID: NCT03251521 Completed - Clinical trials for Post-stroke Spasticity

Pain During Injection With Botulinum Toxin in Post-stroke Spasticity Treatment

DOLOTOX
Start date: March 2012
Phase: N/A
Study type: Observational

The aim of the study was to analyze which step of the procedure of toxin botulinum injection is the most painful between skin break-in, electric stimulation, injection and needle withdrawal.

NCT ID: NCT01251367 Completed - Clinical trials for Post-stroke Spasticity

Dysport® Adult Lower Limb Spasticity Follow-on Study

Start date: June 2011
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to assess the long term safety of Dysport® in hemiparetic subjects with lower limb spasticity due to stroke or traumatic brain injury over repeated treatment cycles.

NCT ID: NCT00460655 Completed - Clinical trials for Cerebrovascular Accident

Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity

Start date: May 2007
Phase: Phase 3
Study type: Interventional

This is a study to confirm the superior efficacy of GSK1358820 over placebo in patients with equinus deformity associated with post-stroke lower limb spasticity using the Modified Ashworth Scale (MAS) ankle score.

NCT ID: NCT00460564 Completed - Clinical trials for Cerebrovascular Accident

Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity

Start date: May 2007
Phase: Phase 3
Study type: Interventional

This is a study to confirm the superior efficacy of a single treatment of GSK1358820 over placebo in patients with post-stroke upper limb spasticity of both the wrist and finger flexors using the Modified Ashworth Scale (MAS) wrist score.